top of page
Connecting Dots
Asha Therapeutics logo-01-2 copy_edited.

Designing novel therapeutics by looking through a PRISM

A Revolutionary Approach to Novel Drug Design

The PRISM™ platform employes a novel set of proprietary algorithms and advanced simulation programs to determine targetability and disease relevance, de novo compound design, chemistry optimization, and predict drug-like properties... all before a single synthetic reaction takes place.

De novo Chemistry and Specific Compound Design No Therapeutics Barriers, Disruptive Potential


No Compound Screening Translates to
an Accelerated Approach to Drug Discovery


The PRISM™ Advantage


Custom designed target specific compounds

ADME & PK optimized for translation to clinic

Ensured synthetic feasibility for CMC readiness

Unparelled speed to development candidate

Robust cost effectivness & reduced risk 

Connecting Dots
asha color.png
  • LinkedIn
  • Twitter

© Copyright 2023 Asha Therapeutics, all rights reserved 

Privacy Policy | Terms of Use

Website designed & maintained by A3 Media

bottom of page